Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
To amend title XVIII of the Social Security Act to limit the coinsurance amount for certain services furnished in an ambulatory surgical center.
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Artificial Intelligence and Machine Learning regulation and Medicare payment; Medicare Coverage of Innovative Medical Device; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment; Co-Pay Cap - H.R. 3006; S. 1776;
Ensuring Patient Access to Critical Breakthrough Products Act
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2026 · third_quarter · Q3
Trade Issues/Policy
issues related to Right to Repair
e-labeling;
Source: Senate LDA
Breakthrough devices- H.R. 5343;
Medicare Beneficiary Co-Pay Fairness Act
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Artificial Intelligence and Machine Learning regulation and Medicare payment; Medicare Coverage of Innovative Medical Device; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment; Co-Pay Cap - H.R. 3006; S. 1776;
Medical Device Electronic Labeling Act
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Medical Device Electronic Labeling Act (H.R. 1539)
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
HR 1691; Medicare and Medicaid Treatment (EMMT) Act; Medicare Coverage of Innovative Medical Devices; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment; Disparities in Healthcare Coverage for Underserved Populations
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Outpatient Surgical Quality and Access Act; H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act of 2023; Food and Drug Administration Regulatory Issues
Breakthrough devices- H.R. 5343;
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2026 · second_quarter · Q2
Artificial Intelligence and Machine Learning regulation and Medicare payment; Medicare Coverage of Innovative Medical Device; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment; Co-Pay Cap - H.R. 3006; S. 1776;
Trade Issues/Policy
e-labeling; Breakthrough devices
Breakthrough devices;
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2026 · first_quarter · Q1
e-labeling; Breakthrough devices
Trade Issues/Policy, Tariffs
Artificial Intelligence and Machine Learning regulation and Medicare payment; Medicare Coverage of Innovative Medical Device; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment; Physician Fee Schedule
Tax Issues; Enhanced ACA Tax Credit
Breakthrough devices;
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2025 · fourth_quarter · Q4
Artificial Intelligence and Machine Learning regulation and Medicare payment; Medicare Coverage of Innovative Medical Device; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment; Physician Fee Schedule
Trade Issues/Policy, Tariffs
Tax Issues; Enhanced ACA Tax Credit
Breakthrough devices;
e-labeling; Breakthrough devices
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2025 · third_quarter · Q3
Tax Issues; ACA Tax Credit
Assorted issues related to the FDA
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2025 · second_quarter · Q2
Trade Issues/Policy
Medical Device Electronic Labeling Act (H.R. 1539)
Assorted issues related to the FDA
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2025 · first_quarter · Q1
Outpatient Surgical Quality and Access Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2024 · fourth_quarter · Q4
ASC copay cap; Outpatient Surgical Quality and Access Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2024 · second_quarter · Q2
John Lewis Equality in Medicare and Medicaid Treatment Act of 2023; Medicare Coverage of Innovative Medical Devices; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment; Artificial Intelligence and Machine Learning regulation and Medicare payment
Ensuring Patient Access to Critical Breakthrough Products Act of 2023; Resident Physician Shortage Reduction Act of 2023;
Artificial Intelligence and Machine Learning regulation and Medicare payment
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2024 · first_quarter · Q1
Ensuring Patient Access to Critical Breakthrough Products Act of 2023; Resident Physician Shortage Reduction Act of 2023;
John Lewis Equality in Medicare and Medicaid Treatment Act of 2023; Medicare Coverage of Innovative Medical Devices; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2023 · fourth_quarter · Q4
HR 1691; Medicare and Medicaid Treatment (EMMT) Act; Medicare Coverage of Innovative Medical Devices; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment; Disparities in Healthcare Coverage for Underserved Populations
Tax Issues; R&D tax policy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2023 · third_quarter · Q3
Equality in Medicaid and Medicare Treatment Act; Medicare and Medicaid Treatment (EMMT) Act; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment
Outpatient Surgical Quality and Access Act; H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act of 2023; Food and Drug Administration Regulatory Issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE